Nancy Lynn Md Snyderman is of Lyra Therapeutics, Inc.. Currently has a direct ownership of 1,025 shares of LYRA, which is worth approximately $266. The most recent transaction as insider was on Dec 16, 2020, when has been sold 1,025 shares (Common Stock) at a price of $9.72 per share, resulting in proceeds of $9,963. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.03K
0% 3M change
0% 12M change
Total Value Held $266

nancy lynn MD snyderman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2020
BUY
Open market or private purchase
$9,963 $9.72 p/Share
1,025 Added 50.0%
1,025 Common Stock

Also insider at

ALKS
Alkermes plc. Healthcare
FHLTU
Future Health ESG Corp. Financial Services
AXNX
Axonics, Inc. Healthcare
nlM

Nancy Lynn Md Snyderman

Dublin,

Track Institutional and Insider Activities on LYRA

Follow Lyra Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYRA shares.

Notify only if

Insider Trading

Get notified when an Lyra Therapeutics, Inc. insider buys or sells LYRA shares.

Notify only if

News

Receive news related to Lyra Therapeutics, Inc.

Track Activities on LYRA